Skip to main content

Table 3 Association between CIP2A expression in patients with acute myeloid leukemia and the response to induction therapy and the relapse rate

From: Prognostic value of CIP2A gene expression in adult Egyptian acute myeloid leukemia patients

 

High CIP2A (n = 21)

Distribution [n (%)]

Low CIP2A (n = 39)

Distribution [n (%)]

P value

Relative risk (95% CI)

Response to induction therapy

0.57

1.2 (0.6–2.54)

 Complete remission

13 (61.9)

27 (69.2)

  

 Resistance

8 (38.1)

12 (30.8)

  

Relapse

0.27

0.4 (0.11–1.99)

 Still in complete remission

19 (90.5)

31 (79.8)

  

 Relapsed

2 (9.5)

8 (20.2)

 Â